169 related articles for article (PubMed ID: 24750838)
1. [Clinical efficacy of letrozole in boys with idiopathic central precocious puberty].
Zhao X; Zhang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):397-400. PubMed ID: 24750838
[TBL] [Abstract][Full Text] [Related]
2. Novel treatment of short stature with aromatase inhibitors.
Dunkel L; Wickman S
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531
[TBL] [Abstract][Full Text] [Related]
3. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
[TBL] [Abstract][Full Text] [Related]
4. Treatment of delayed male puberty: efficacy of aromatase inhibition.
Dunkel L; Wickman S
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1541-6. PubMed ID: 11837512
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
Hero M; Norjavaara E; Dunkel L
J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
[TBL] [Abstract][Full Text] [Related]
6. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
Hero M; Wickman S; Dunkel L
Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
Salehpour S; Alipour P; Razzaghy-Azar M; Ardeshirpour L; Shamshiri A; Monfared MF; Gharib A
Horm Res Paediatr; 2010; 74(6):428-35. PubMed ID: 20628237
[TBL] [Abstract][Full Text] [Related]
8. Novel treatment of delayed male puberty with aromatase inhibitors.
Dunkel L; Wickman S
Horm Res; 2002; 57 Suppl 2():44-52. PubMed ID: 12065927
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome.
Wikström AM; Bay K; Hero M; Andersson AM; Dunkel L
J Clin Endocrinol Metab; 2006 Nov; 91(11):4705-8. PubMed ID: 16926256
[TBL] [Abstract][Full Text] [Related]
10. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
Mauras N; Ross JL; Gagliardi P; Yu YM; Hossain J; Permuy J; Damaso L; Merinbaum D; Singh RJ; Gaete X; Mericq V
J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
[TBL] [Abstract][Full Text] [Related]
11. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
Liang Y; Wei H; Zhang JL; Hou L; Luo XP
Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
[TBL] [Abstract][Full Text] [Related]
13. Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty.
Wiromrat P; Panamonta O
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):227-233. PubMed ID: 30592192
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.
Estrada A; Boyce AM; Brillante BA; Guthrie LC; Gafni RI; Collins MT
Eur J Endocrinol; 2016 Nov; 175(5):477-483. PubMed ID: 27562402
[TBL] [Abstract][Full Text] [Related]
15. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial.
Wickman S; Sipilä I; Ankarberg-Lindgren C; Norjavaara E; Dunkel L
Lancet; 2001 Jun; 357(9270):1743-8. PubMed ID: 11403810
[TBL] [Abstract][Full Text] [Related]
16. Are aromatase inhibitors in boys with predicted short stature and/or rapidly advancing bone age effective and safe?
Ferris JA; Geffner ME
J Pediatr Endocrinol Metab; 2017 Mar; 30(3):311-317. PubMed ID: 28207416
[TBL] [Abstract][Full Text] [Related]
17. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
Hero M; Mäkitie O; Kröger H; Nousiainen E; Toiviainen-Salo S; Dunkel L
Horm Res; 2009; 71(5):290-7. PubMed ID: 19339794
[TBL] [Abstract][Full Text] [Related]
18. Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature.
Krebs A; Moske-Eick O; Doerfer J; Roemer-Pergher C; van der Werf-Grohmann N; Schwab KO
J Pediatr Endocrinol Metab; 2012; 25(5-6):581-5. PubMed ID: 22876562
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of domestic leuprorelin in girls with idiopathic central precocious puberty: a multicenter, randomized, parallel, controlled trial.
Li WJ; Gong CX; Guo MJ; Xing J; Li T; Song WH; Luo XP; Wu D; Liang JP; Cao BY; Gu Y; Su C; Liang XJ; Liu M; Wang R; Li FT
Chin Med J (Engl); 2015 May; 128(10):1314-20. PubMed ID: 25963350
[TBL] [Abstract][Full Text] [Related]
20. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
Lenz AM; Shulman D; Eugster EA; Rahhal S; Fuqua JS; Pescovitz OH; Lewis KA
Pediatrics; 2010 Sep; 126(3):e728-33. PubMed ID: 20713483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]